Nippon Chemiphar Co., Ltd. (TYO:4539)
Japan · Delayed Price · Currency is JPY 1,515.00
-13.00 (-0.85%)
Nov 13, 2026, 2:14 PM JST
Nippon Chemiphar Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 32,979 | 33,090 | 32,570 | 30,748 | 31,559 | 32,506 |
Revenue Growth | 0.31% | 1.60% | 5.93% | -2.57% | -2.91% | 3.06% |
Gross Profit Gross Profit Growth | 7,864 | 8,397 | 8,746 | 7,738 | 8,185 | 9,074 |
Operating Income Operating Income Growth | -640 | 180 | 607 | -494 | -240 | 826 |
Net Income Net Income Growth | -477 | 198 | 294 | -180 | 339 | 700 |
Earnings Per Share EPS Growth | -131.71 | 54.79 | 81.48 | -49.88 | 93.92 | 194.09 |
EPS Growth | - | -32.76% | - | - | -51.61% | 40.96% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Others Others Growth | 1,324 | 1,242 | 1,264 | 1,146 | 1,038 | 1,035 |
Pharmaceutical Business Pharmaceutical Business Growth | 31,738 | 31,868 | 31,393 | 29,620 | 30,552 | 31,512 |
Unallocated Adjustment Unallocated Adjustment Growth | -82 | -20 | -86 | -18 | -31 | -42 |
Total Total Growth | 32,980 | 33,090 | 32,571 | 30,748 | 31,559 | 32,505 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 4,286 | 5,342 | 7,021 | 9,200 | 10,529 | 11,645 |
Total Debt Total Debt Growth | 17,489 | 16,584 | 18,061 | 16,981 | 15,230 | 14,788 |
Net Cash (Debt) Net Cash Growth | -13,203 | -11,242 | -11,040 | -7,781 | -4,701 | -3,143 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3645.72 | -3110.91 | -3059.76 | -2156.10 | -1302.43 | -871.48 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -2,694 | 620 | -265 | 296 | -916 | 1,801 |
Capital Expenditures CapEx Growth | -1,044 | -851 | -1,595 | -2,627 | -1,005 | -725 |
Free Cash Flow Free Cash Flow Growth | -3,738 | -231 | -1,860 | -2,331 | -1,921 | 1,076 |
Free Cash Flow Growth | - | - | - | - | - | -4.10% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 23.84% | 25.38% | 26.85% | 25.17% | 25.94% | 27.91% |
Operating Margin | -1.94% | 0.54% | 1.86% | -1.61% | -0.76% | 2.54% |
Pretax Margin | -2.02% | 0.67% | 0.78% | -0.65% | 1.52% | 3.00% |
Profit Margin | -1.45% | 0.60% | 0.90% | -0.58% | 1.07% | 2.15% |
FCF Margin | -11.33% | -0.70% | -5.71% | -7.58% | -6.09% | 3.31% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 50.000 | 50.000 | 50.000 | 50.000 | 50.000 | 50.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 3.30% | 2.82% | 3.38% | 3.00% | 2.72% | 2.40% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | - | 32.43 | 18.15 | - | 19.58 | 10.75 |
Forward PE | - | 12.06 | 12.06 | 12.06 | 12.06 | 12.06 |
P/FCF Ratio | - | - | - | - | - | 6.99 |
PS Ratio | 0.17 | 0.19 | 0.16 | 0.20 | 0.21 | 0.23 |